D3 Tenders | Herpes zoster, inactivated vaccine (2027)

Notice Information

Get alerts for notices like these

Notice Title

Herpes zoster, inactivated vaccine (2027)

Notice Description

The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme. This notice provides an indication to the market of UKHSA's intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice.

Procurement Information

The following conditions are met in relation to the public contract under Schedule 5, Paragraph 5 (a, b) of the Procurement Act 2023-- (a) due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works.

Notice Details

Get alerts for notices like these

Publication & Lifecycle

Open Contracting ID: ocds-h6vhtk-066916
Publication Source: Find A Tender Service
Latest Notice: https://www.find-tender.service.gov.uk/Notice/022642-2026
Current Stage: Award
All Stages: Award

Procurement Classification

Notice Type: UK5 - Transparency Notice
Procurement Type: Standard
Procurement Category: Goods
Procurement Method: Direct
Procurement Method Details: Direct award
Tender Suitability: Not specified
Awardee Scale: Large

Common Procurement Vocabulary (CPV)

CPV Divisions: 33 - Medical equipments, pharmaceuticals and personal care products
CPV Codes: 33651600 - Vaccines

Notice Value(s)

Tender Value: Not specified
Lots Value: Not specified
Awards Value: Not specified
Contracts Value: Not specified

Notice Dates

Publication Date: 13 Mar 2026Yesterday
Submission Deadline: Not specified
Future Notice Date: Not specified
Award Date: 13 Mar 2026Yesterday
Contract Period: 31 Mar 2027 - 31 Mar 2029 2-3 years
Recurrence: Not specified

Notice Status

Tender Status: Complete
Lots Status: Complete
Awards Status: Pending
Contracts Status: Not Specified

Buyer & Supplier

Get alerts for notices like these

Contracting Authority (Buyer)

Main Buyer: SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY
Contact Name: Available with D3 Tenders Premium →
Contact Email: Available with D3 Tenders Premium →
Contact Phone: Available with D3 Tenders Premium →

Buyer Location

Locality: LONDON
Postcode: E14 4PU
Post Town: East London
Country: England
Major Region (ITL 1): TLI London
Basic Region (ITL 2): TLI4 Inner London - East
Small Region (ITL 3): TLI42 Tower Hamlets
Delivery Location: Not specified
Local Authority: Tower Hamlets
Electoral Ward: Canary Wharf
Westminster Constituency: Poplar and Limehouse

Supplier Information

Number of Suppliers: 1
Supplier Name: GLAXOSMITHKLINE

Further Information

Notice Documents

https://www.find-tender.service.gov.uk/Notice/022642-2026
13th March 2026 - Transparency notice on Find a Tender

Notice URLs

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

Download

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-066916-2026-03-13T08:02:26Z",
    "date": "2026-03-13T08:02:26Z",
    "ocid": "ocds-h6vhtk-066916",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PBMQ-7576-DVGW",
            "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PBMQ-7576-DVGW"
            },
            "address": {
                "streetAddress": "10 South Colonnade",
                "locality": "London",
                "postalCode": "E14 4PU",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI42"
            },
            "contactPoint": {
                "email": "vmc.vaccines@ukhsa.gov.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.gov.uk/government/organisations/uk-health-security-agency",
                "classifications": [
                    {
                        "id": "publicAuthorityCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - central government"
                    }
                ]
            }
        },
        {
            "id": "GB-PPON-PNVC-2547-YXMP",
            "name": "GlaxoSmithKline UK Limited",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PNVC-2547-YXMP"
            },
            "address": {
                "streetAddress": "79 New Oxford Street",
                "locality": "London",
                "postalCode": "WC1A 1DG",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI31"
            },
            "contactPoint": {
                "email": "customercontactuk@gsk.com"
            },
            "roles": [
                "supplier"
            ],
            "details": {
                "scale": "large",
                "vcse": false
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PBMQ-7576-DVGW",
        "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency"
    },
    "tender": {
        "id": "CM/PHV/27/C384964",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Herpes zoster, inactivated vaccine (2027)",
        "description": "The provision of a vaccine to protect against herpes zoster, also known as shingles, to be used in the national immunisation programme. This notice provides an indication to the market of UKHSA's intention to enter into negotiations with GlaxoSmithKline (UK) Limited, with the objective of awarding a contract for the supply of the herpes zoster, inactivated (shingles) vaccine, in accordance with JCVI advice.",
        "status": "complete",
        "procurementMethod": "direct",
        "procurementMethodDetails": "Direct award",
        "procurementMethodRationale": "The following conditions are met in relation to the public contract under Schedule 5, Paragraph 5 (a, b) of the Procurement Act 2023-- (a) due to a particular supplier having intellectual property rights or other exclusive rights, only that supplier can supply the goods, services or works required, and (b)there are no reasonable alternatives to those goods, services or works.",
        "lots": [
            {
                "id": "1",
                "status": "complete"
            }
        ],
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest",
                "description": "Not published"
            }
        ],
        "riskDetails": "The below known unknown risks has been identified, which may require modification of the contract under paragraph 5 of Schedule 8 to the PA 2023 if one of the below identified risks materialise. Risk 1: The COVID-19 pandemic led to lockdown events, which disrupted the distribution and uptake of some national immunisation campaigns. The forecast delivery and stock requirements were substantially changed as a result. An ongoing risk is the materialisation of a UK health emergency or global pandemic, which may materialise in any given year. How the risk may impact on the performance of the contract: A health emergency or pandemic may materially affect the uptake of the herpes zoster, inactivated vaccine. Continued delivery of the vaccine within the original term of the contract could jeopardise stock management and effective use of vaccines before expiry. Why is it not possible to address the potential impact of such risks? UKHSA and suppliers cannot reasonably predict the occurrence of a pandemic. UKHSA cannot determine an effective delivery schedule and contract term which would be effective during a pandemic to mitigate the risk of reduced uptake.",
        "procurementMethodRationaleClassifications": [
            {
                "id": "singleSuppliersIntellectualPropertyExclusiveRights"
            }
        ]
    },
    "awards": [
        {
            "id": "1",
            "title": "Herpes zoster, inactivated vaccine (2027)",
            "status": "pending",
            "value": {
                "amountGross": 0,
                "amount": 0,
                "currency": "GBP"
            },
            "mainProcurementCategory": "goods",
            "aboveThreshold": true,
            "suppliers": [
                {
                    "id": "GB-PPON-PNVC-2547-YXMP",
                    "name": "GlaxoSmithKline UK Limited"
                }
            ],
            "items": [
                {
                    "id": "1",
                    "additionalClassifications": [
                        {
                            "scheme": "CPV",
                            "id": "33651600",
                            "description": "Vaccines"
                        }
                    ],
                    "deliveryAddresses": [
                        {
                            "region": "UK",
                            "country": "GB",
                            "countryName": "United Kingdom"
                        }
                    ],
                    "relatedLot": "1"
                }
            ],
            "contractPeriod": {
                "startDate": "2027-04-01T00:00:00+01:00",
                "endDate": "2029-03-31T23:59:59+01:00",
                "maxExtentDate": "2031-03-31T23:59:59+01:00"
            },
            "hasRenewal": true,
            "renewal": {
                "description": "The Authority has the option to extend for a period or periods of up to an additional 24 months, subject to negotiation."
            },
            "relatedLots": [
                "1"
            ],
            "documents": [
                {
                    "id": "022642-2026",
                    "documentType": "awardNotice",
                    "noticeType": "UK5",
                    "description": "Transparency notice on Find a Tender",
                    "url": "https://www.find-tender.service.gov.uk/Notice/022642-2026",
                    "datePublished": "2026-03-13T08:02:26Z",
                    "format": "text/html"
                }
            ],
            "milestones": [
                {
                    "id": "1",
                    "type": "futureSignatureDate",
                    "dueDate": "2026-11-06T23:59:59Z",
                    "status": "scheduled"
                }
            ]
        }
    ],
    "language": "en"
}